The New Frontier: Understanding the Schizophrenia Market
The Schizophrenia Market is a vital and evolving segment of the global pharmaceutical industry, addressing a severe, chronic mental health disorder that affects an estimated 24 million people worldwide. Schizophrenia is characterized by profound disruptions in thinking, perception, and emotion, requiring lifelong management. Currently valued at approximately USD 12.91 billion in 2025,...
0 Comments 0 Shares 158 Views 0 Reviews